Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2013
A dose-escalation study of SAR3419, an anti-CD19 antibody maytansinoid conjugate, administered by intravenous infusion once weekly in patients with relapsed/refractory B-cell non-Hodgkin lymphomaVincent Ribrag, Jehan Dupuis, Herve Tilly, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 25, 2024
Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccineSimon B Gressens, Vincent Enouf, Antoine Créon, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 8, 2022
Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignanciesSimon B Gressens, Slim Fourati, Anne Le Bouter, et al.
Blood|March 22, 2018
Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL studyAnne Ségolène Cottereau, Annibale Versari, Stefano Luminari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2016
Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter StudiesMichel Meignan, Anne Ségolène Cottereau, Annibale Versari, et al.
British Journal of Haematology|September 10, 2016
Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective studyPhilip A Thompson, Vincent Lévy, Constantine S Tam, et al.
Pageof 9